Showing 661 - 680 results of 226,614 for search '(( a e decrease ) OR ( 10 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.62s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665
  6. 666

    siRNA-based knockdown of <i>CLU</i> results in decreased VWF and CLU protein expression but no change in <i>VWF</i> mRNA content. by Allaura A. Cox (17980027)

    Published 2024
    “…<p>qPCR analysis of <i>CLU</i> expression demonstrates significant decrease in <i>CLU</i> expression after <i>CLU</i> siRNA knockdown (2A). …”
  7. 667
  8. 668
  9. 669
  10. 670

    CPT treatment is associated with decreased production of sAPPα and Aβ. by Tina Fiorelli (255278)

    Published 2013
    “…<p>A) H4-APP cells were treated with or without 10 βM CPT and tissue culture supernatants were collected at every hour for six hours. …”
  11. 671
  12. 672

    Phenotypic delay decreases the probability of a bacterial infection surviving antibiotic treatment. by Martín Carballo-Pacheco (8911910)

    Published 2020
    “…<p>(a-b) A schematic of the simulated infection: a population of exponentially replicating sensitive cells is exposed to an antibiotic when the population reaches 10<sup>7</sup> cells. …”
  13. 673
  14. 674
  15. 675
  16. 676
  17. 677

    (a)-(c) Stable contribution-space of three populations with decreasing comparative advantage. by Joshua Tasoff (776736)

    Published 2015
    “…<b>(f)</b> Dotted line cross-section from plot (e) showing growth rate as a function of <i>species-1</i> contribution for a fixed <i>species-2</i> contribution of .…”
  18. 678
  19. 679

    Targeting <i>A20</i> decreases glioma stem cell growth. by Anita B. Hjelmeland (104655)

    Published 2010
    “…An asterisk (*) indicates <i>p</i><0.05 with ANOVA comparison of nontargeting shRNA to <i>A20</i> shRNAs. (E) Cell-cycle analysis demonstrates that targeting <i>A20</i> expression decreases the percentage of cells in the S phase of the cell cycle in glioma stem cells isolated from T4121, T08-837, and T4597 cells patient specimen passaged short term in immunocompromised mice. …”
  20. 680